Document Detail


High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
MedLine Citation:
PMID:  19698944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The cholesterol esterifying enzyme, lecithin:cholesterol acyltransferase (LCAT), is crucial in high density lipoprotein (HDL) metabolism. The role of LCAT activity on incident cardiovascular disease (CVD) is unknown. We determined the association of incident CVD with plasma LCAT activity, and evaluated whether LCAT may modify the cardioprotective effect of higher HDL cholesterol. In a community-based prospective nested case-control study (PREVEND cohort), an exogenous substrate assay was used to measure plasma LCAT activity in 116 men who developed CVD (cases) and in 111 male controls. Plasma LCAT activity was 5% higher in cases (P=0.027) in association with higher total cholesterol, non-HDL cholesterol and triglycerides. Age-adjusted incident CVD was increased with higher LCAT activity (continuous variable: hazard ratio (HR) 1.23; 95% CI 1.01-1.49, P=0.037; upper quartile vs. lowest 3 quartiles: HR 1.60; 95% CI 1.07-2.39, P=0.021). This relationship was not significant after adjustment for lipids. Compared to subjects with HDL cholesterol above the median and lower LCAT activity (lowest 3 quartiles) the age-adjusted cardiovascular risk was elevated in subjects with similarly higher HDL cholesterol and higher LCAT activity (HR 2.38; 95% CI 1.27-4.49, P=0.007), lower HDL cholesterol and lower LCAT activity (HR 2.58; 95% CI 1.64-4.49, P<0.001) and lower HDL cholesterol and higher LCAT activity (HR 2.76; 95% CI 1.58-4.83, P<0.001). These HRs were unchanged after non-HDL cholesterol and triglyceride adjustment. In conclusion, high plasma LCAT activity does not predict reduced CVD risk, and may attenuate cardioprotection associated with higher HDL cholesterol.
Authors:
Robin P F Dullaart; Frank Perton; Melanie M van der Klauw; Hans L Hillege; Wim J Sluiter;
Related Documents :
8866834 - Fce 27677: a novel inhibitor of acyl-coa: cholesterol acyltransferase with potent oral ...
3700364 - Selectivity and contribution of lecithin: cholesterol acyltransferase to plasma cholest...
971344 - Effect of the phospholipid vehicle on the transport of cholesterol in rats.
6947824 - Cholesterol solubilization by short-chain lecithins: characterization of mixed micelles...
213854 - Effects of intravenous nutrition on tumor growth and host immunocompetence in malnouris...
11989744 - Effect of dietary supplemental levels of vitamin a on the egg production and immune res...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-07-30
Journal Detail:
Title:  Atherosclerosis     Volume:  208     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-04-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  537-42     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Endocrinology, University of Groningen and University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands. r.p.f.dullaart@int.umcg.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cardiovascular Diseases / blood*,  epidemiology*,  prevention & control
Case-Control Studies
Cholesterol, HDL / metabolism*
Cohort Studies
Gene Expression Regulation, Enzymologic
Humans
Incidence
Male
Middle Aged
Phosphatidylcholine-Sterol O-Acyltransferase / blood*
Proportional Hazards Models
Prospective Studies
Triglycerides / metabolism
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Triglycerides; EC 2.3.1.43/Phosphatidylcholine-Sterol O-Acyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alternative fixation method for open femoral fractures from a damage control orthopaedics perspectiv...
Next Document:  Changes to the viscoelastic properties of brain tissue after traumatic axonal injury.